• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. STAY SAFE/LUER LOCK CATHETER EXT. 12 IN.; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. STAY SAFE/LUER LOCK CATHETER EXT. 12 IN.; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Model Number 050-95004
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abdominal Pain (1685); Peritonitis (2252)
Date of Event 02/20/2023
Type of Reportable Event Serious Injury
Event or Problem Description
A peritoneal dialysis (pd) patient on continuous cycling peritoneal dialysis (ccpd) for renal replacement therapy (rrt) contacted customer support and reported they got peritonitis while on the machine.Upon follow up, the peritoneal dialysis registered nurse (pdrn) stated that the patient presented to the outpatient home dialysis unit on (b)(6) 2023 with complaints of abdominal pain and cloudy peritoneal effluent fluid.A peritoneal effluent fluid culture and cell count (wbc = 3305 u/l, polymorphs = 88%) were collected, and the patient was diagnosed with peritonitis.The patient was treated as an outpatient with intraperitoneal (ip) vancomycin (per vancomycin level) and ceftazidime 1500 mg daily for 14-21 days.The patient¿s peritoneal effluent culture result returned negative for growth on (b)(6) 2023, and the patient¿s antibiotics were continued.The patient continues to undergo continuous cyclic pd (ccpd) utilizing the same liberty select cycler and is recovering from the serious adverse events.The pdrn attributed causality to a disconnection event, when the patient¿s pd catheter extension set disconnected from the liberty cycler set due to inadequate tightening.The patient reported the liberty cycler set fell to the floor, and they reconnected without utilizing a new set-up.Per the pdrn, the events were unrelated to any fresenius product(s), drug(s), and/or device(s) deficiency or malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STAY SAFE/LUER LOCK CATHETER EXT. 12 IN.
Common Device Name
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
MDR Report Key16491560
Report Number3023981687-2023-00050
Device Sequence Number6787680
Product Code KDJ
UDI-Device Identifier00840861100781
UDI-Public00840861100781
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K173593
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 03/06/2023
Report Date (Section F) 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number050-95004
Device Catalogue Number050-95004
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date02/27/2023
Device AgeMO
Event Location Home
Date Report to Manufacturer03/06/2023
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/06/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DELFLEX PD FLUID.; LIBERTY SELECT CYCLER.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age67 YR
Patient SexFemale
Patient Weight47 KG
Date Report Sent to FDA03/06/2023
-
-